PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients OSE Immunotherapeutics welcomes FDA Orphan Drug Designation granted to Pegrizeprument (VEL-101) for prevention of organ rejection in heart transplant patients, a novel immunomodulatory treatment developed in partnership with Veloxis Pharmaceuticals Orphan Drug Designation Transplant Pegrizeprument VEL-101 Organ Rejection
PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago FORVIA to Sell its Interiors Business Group to Apollo Funds FORVIA announces sale of Interiors Business Group to Apollo Funds for €1.82 billion, focusing on strategic initiatives and debt reduction Sale Debt Reduction Apollo Funds Forvia Interiors Business Group
PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago FORVIA: CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS OF FORVIA SUBJECT TO APPROVAL BY THE 2026 ANNUAL GENERAL MEETING FORVIA announces changes in Board of Directors composition with Pierre-André de Chalendar appointment and resignation of Michel de Rosen. Details on the 2026 Annual General Meeting Board Of Directors Annual General Meeting Resignation Forvia Pierre-André De Chalendar
PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago FORVIA annonce la cession de son activité Intérieurs à Apollo Funds FORVIA annonce la cession de son activité Intérieurs à Apollo pour 1,82 milliard d'euros, renforçant ainsi sa stratégie IGNITE et sa structure financière Stratégie Cession Forvia Apollo Intérieurs
PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago FORVIA : CHANGEMENTS DANS LA COMPOSITION DU CONSEIL D'ADMINISTRATION DE FORVIA SOUMIS A L'APPROBATION DE SON ASSEMBLEE GENERALE ANNUELLE 2026 Réorganisation du Conseil d'administration de FORVIA avec la nomination de Pierre-André de Chalendar en remplacement de Michel de Rosen. FORVIA, société internationale de technologie automobile, annonce des changements clés Conseil D'administration Nominations Industrie Automobile Forvia Pierre-André De Chalendar
PRESS RELEASE published on 04/27/2026 at 07:30, 12 days ago Exosens delivers strong Q1 2026 performance, with accelerating defense momentum in digital imaging and night vision; Fully on track to deliver on 2026 guidance Exosens reports strong Q1 2026 performance with accelerating defense momentum in digital imaging and night vision. On track to deliver on 2026 guidance Exosens Night Vision Q1 2026 Defense Momentum Digital Imaging
PRESS RELEASE published on 04/27/2026 at 07:00, 12 days 1 hour ago Nordex Group reports solid Q1/2026 results with continued margin improvement year on year Nordex Group reports solid Q1/2026 results with continued margin improvement year on year. Sales growth, increased EBITDA, and positive net income. Full year 2026 guidance confirmed EBITDA Sales Growth Nordex Group Margin Improvement Q1/2026 Results
PRESS RELEASE published on 04/27/2026 at 06:50, 12 days 1 hour ago Leclanché SA renforce sa structure de capital par conversion de dette en fonds propres Leclanché SA renforce sa structure de capital par conversion de dette en fonds propres. Annonce événementielle au sens de l'art. 53 RC (SIX) - YVERDON-LES-BAINS, Suisse - Leclanché, fournisseur mondial de solutions de stockage d'énergie, convertit CHF 10,0 millions de dette en capitaux propres Croissance Stockage D'Énergie Fonds Propres Conversion De Dette Leclanché SA
PRESS RELEASE published on 04/27/2026 at 06:50, 12 days 1 hour ago Leclanché SA: Strengthens its Capital Structure through Debt-to-Equity Conversion Leclanché SA strengthens its capital structure through a debt-to-equity conversion, reinforcing its balance sheet with CHF 10 million converted to equity to support strategic growth initiatives Strategic Growth Balance Sheet Capital Structure Leclanché SA Debt-to-equity Conversion
PRESS RELEASE published on 04/27/2026 at 06:20, 12 days 1 hour ago Flagship Tablet to Highlight Huawei Innovative Product Launch in Bangkok Huawei announces 'Now Is Your Spark' Innovative Launch Event in Bangkok unveiling flagship tablet MatePad Pro Max, WATCH FIT 5 Series, and nova 15 Max for global consumers Smartphones Wearables Huawei Innovative Launch Event Flagship Tablet
Published on 05/09/2026 at 01:30, 6 hours 50 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 8 hours 20 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 11 hours 42 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 13 hours 7 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 13 hours 17 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 13 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 13 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 13 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 13 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 13 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL